Take Solutions Limited
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient c… Read more
Take Solutions Limited (TAKE) - Net Assets
Latest net assets as of September 2025: ₹256.29 Million INR
Based on the latest financial reports, Take Solutions Limited (TAKE) has net assets worth ₹256.29 Million INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹352.13 Million) and total liabilities (₹95.84 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹256.29 Million |
| % of Total Assets | 72.78% |
| Annual Growth Rate | 10.65% |
| 5-Year Change | -98.17% |
| 10-Year Change | -96.94% |
| Growth Volatility | 90.64 |
Take Solutions Limited - Net Assets Trend (2002–2025)
This chart illustrates how Take Solutions Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Take Solutions Limited (2002–2025)
The table below shows the annual net assets of Take Solutions Limited from 2002 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹205.27 Million | +331.34% |
| 2024-03-31 | ₹-88.73 Million | -108.17% |
| 2023-03-31 | ₹1.09 Billion | -39.87% |
| 2022-03-31 | ₹1.81 Billion | -83.93% |
| 2021-03-31 | ₹11.24 Billion | -29.08% |
| 2020-03-31 | ₹15.85 Billion | +3.80% |
| 2019-03-31 | ₹15.27 Billion | +14.27% |
| 2018-03-31 | ₹13.37 Billion | +40.24% |
| 2017-03-31 | ₹9.53 Billion | +41.94% |
| 2016-03-31 | ₹6.72 Billion | +15.68% |
| 2015-03-31 | ₹5.80 Billion | +11.99% |
| 2014-03-31 | ₹5.18 Billion | +11.21% |
| 2013-03-31 | ₹4.66 Billion | +22.80% |
| 2012-03-31 | ₹3.80 Billion | +34.67% |
| 2011-03-31 | ₹2.82 Billion | -26.90% |
| 2010-03-31 | ₹3.86 Billion | -0.07% |
| 2009-03-31 | ₹3.86 Billion | +29.28% |
| 2008-03-31 | ₹2.98 Billion | +237.07% |
| 2007-03-31 | ₹885.44 Million | +172.47% |
| 2006-03-31 | ₹324.97 Million | +135.28% |
| 2005-03-31 | ₹138.12 Million | +26.51% |
| 2004-03-31 | ₹109.18 Million | +44.94% |
| 2003-03-31 | ₹75.33 Million | +276.65% |
| 2002-03-31 | ₹20.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Take Solutions Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 633196000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₹146.22 Million | 71.23% |
| Other Comprehensive Income | ₹122.39 Million | 59.62% |
| Other Components | ₹6.27 Billion | 3053.84% |
| Total Equity | ₹205.27 Million | 100.00% |
Take Solutions Limited Competitors by Market Cap
The table below lists competitors of Take Solutions Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hainan Poly Pharm Co Ltd
SHE:300630
|
$36.69 Million |
|
BranchOut Food Inc. Common Stock
NASDAQ:BOF
|
$36.69 Million |
|
Tailyn Technologies
TWO:5353
|
$36.71 Million |
|
Enterprise Group Inc
PINK:ETOLF
|
$36.72 Million |
|
PIE Industrial Bhd
KLSE:7095
|
$36.68 Million |
|
Grupa Azoty Zaklady Chemiczne Police SA
WAR:PCE
|
$36.67 Million |
|
Bai Sha Technology Co Ltd
TWO:8401
|
$36.67 Million |
|
NPC Co. Ltd
KO:004250
|
$36.66 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Take Solutions Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -88,730,000 to 205,270,000, a change of 294,000,000.
- Net income of 374,670,000 contributed positively to equity growth.
- Dividend payments of 390,000 reduced retained earnings.
- Other comprehensive income decreased equity by 5,030,000.
- Other factors decreased equity by 75,250,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹374.67 Million | +182.53% |
| Dividends Paid | ₹390.00K | -0.19% |
| Other Comprehensive Income | ₹-5.03 Million | -2.45% |
| Other Changes | ₹-75.25 Million | -36.66% |
| Total Change | ₹- | % |
Book Value vs Market Value Analysis
This analysis compares Take Solutions Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 28.84x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 4.31x to 28.84x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-03-31 | ₹9.39 | ₹40.48 | x |
| 2008-03-31 | ₹26.49 | ₹40.48 | x |
| 2009-03-31 | ₹31.11 | ₹40.48 | x |
| 2010-03-31 | ₹30.48 | ₹40.48 | x |
| 2011-03-31 | ₹21.17 | ₹40.48 | x |
| 2012-03-31 | ₹28.42 | ₹40.48 | x |
| 2013-03-31 | ₹34.97 | ₹40.48 | x |
| 2014-03-31 | ₹39.10 | ₹40.48 | x |
| 2015-03-31 | ₹43.65 | ₹40.48 | x |
| 2016-03-31 | ₹51.96 | ₹40.48 | x |
| 2017-03-31 | ₹71.22 | ₹40.48 | x |
| 2018-03-31 | ₹100.61 | ₹40.48 | x |
| 2019-03-31 | ₹103.57 | ₹40.48 | x |
| 2020-03-31 | ₹107.73 | ₹40.48 | x |
| 2021-03-31 | ₹76.92 | ₹40.48 | x |
| 2022-03-31 | ₹12.38 | ₹40.48 | x |
| 2023-03-31 | ₹7.43 | ₹40.48 | x |
| 2024-03-31 | ₹-0.61 | ₹40.48 | x |
| 2025-03-31 | ₹1.40 | ₹40.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Take Solutions Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 182.53%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.78x
- Recent ROE (182.53%) is above the historical average (-3.94%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 4.32% | 3.32% | 0.95x | 1.36x | ₹-5.89 Million |
| 2005 | 21.09% | 10.05% | 1.42x | 1.47x | ₹14.68 Million |
| 2006 | 32.09% | 20.00% | 0.53x | 3.01x | ₹66.35 Million |
| 2007 | 38.98% | 18.14% | 0.70x | 3.05x | ₹245.66 Million |
| 2008 | 18.35% | 18.35% | 0.74x | 1.35x | ₹245.47 Million |
| 2009 | 14.47% | 16.10% | 0.65x | 1.38x | ₹166.71 Million |
| 2010 | 9.92% | 10.32% | 0.69x | 1.40x | ₹-2.92 Million |
| 2011 | 28.88% | 14.70% | 0.85x | 2.31x | ₹480.85 Million |
| 2012 | 25.03% | 12.16% | 0.95x | 2.17x | ₹513.83 Million |
| 2013 | 18.90% | 9.55% | 0.99x | 1.99x | ₹374.28 Million |
| 2014 | 12.34% | 7.11% | 0.95x | 1.83x | ₹109.95 Million |
| 2015 | 13.33% | 9.57% | 0.79x | 1.76x | ₹174.41 Million |
| 2016 | 18.95% | 11.62% | 0.85x | 1.92x | ₹565.25 Million |
| 2017 | 15.71% | 10.64% | 0.98x | 1.51x | ₹519.83 Million |
| 2018 | 12.08% | 10.11% | 0.86x | 1.39x | ₹276.27 Million |
| 2019 | 11.68% | 8.70% | 0.87x | 1.54x | ₹254.73 Million |
| 2020 | -0.78% | -0.56% | 0.89x | 1.58x | ₹-1.70 Billion |
| 2021 | -40.19% | -58.40% | 0.42x | 1.64x | ₹-5.64 Billion |
| 2022 | -432.08% | -119.86% | 0.53x | 6.76x | ₹-8.00 Billion |
| 2023 | -92.32% | -53.03% | 0.84x | 2.07x | ₹-1.11 Billion |
| 2024 | 0.00% | -182.33% | 0.74x | 0.00x | ₹-1.19 Billion |
| 2025 | 182.53% | 0.00% | 0.00x | 1.78x | ₹354.14 Million |
Industry Comparison
This section compares Take Solutions Limited's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $14,695,406,990
- Average return on equity (ROE) among peers: -6.23%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Take Solutions Limited (TAKE) | ₹256.29 Million | 4.32% | 0.37x | $36.69 Million |
| Anthem Biosciences Ltd (ANTHEM) | $17.41 Billion | 22.13% | 0.16x | $17.29 Million |
| BALAXI PHARMACEUTICALS LIMITED (BALAXI) | $15.55 Million | -49.65% | 0.08x | $10.46 Million |
| Biocon Limited (BIOCON) | $14.77 Billion | 31.41% | 0.41x | $2.54 Billion |
| Blue Jet Healthcare Limited (BLUEJET) | $8.45 Billion | 19.37% | 0.25x | $134.93 Million |
| Concord Biotech Limited (CONCORDBIO) | $18.13 Billion | 20.50% | 0.12x | $346.78 Million |
| Dishman Carbogen Amcis Limited (DCAL) | $9.29 Billion | 6.11% | 1.42x | $103.76 Million |
| Haleos Labs Limited (HALEOSLABS) | $1.06 Billion | 16.78% | 1.56x | $129.20K |
| Lyka Labs Limited (LYKALABS) | $582.36 Million | -29.66% | 3.04x | $8.51 Million |
| ONESOURCE SPECIALTY PHARMA LTD (ONESOURCE) | $75.29 Billion | 0.00% | 0.00x | $1.21 Billion |
| Panacea Biotec Limited (PANACEABIO) | $1.96 Billion | -99.24% | 6.10x | $56.46 Million |